Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Bulletin Barbados.
Press releases published on September 3, 2025
Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate
GlobeNewswire
·
September 3, 2025
Strong immune response after third yearly booster dose in children and adults Significant anamnestic antibody response across all six serotypes No safety concerns observed in any age group by independent Data Monitoring Committee (DMC), consistent with …
Valneva annonce de nouvelles données positives d’innocuité et d’immunogénicité de Phase 2 pour le candidat vaccin contre la maladie de Lyme
GlobeNewswire
·
September 3, 2025
Forte réponse immunitaire chez les enfants et les adultes après la troisième vaccination annuelle de rappel Forte réponse anamnestique observée pour les six sérotypes Aucun problème de sécurité observé dans toutes les tranches d’âge par le comité …
NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer
GlobeNewswire
·
September 3, 2025
NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer Seasoned clinical development leader brings deep expertise in neuromuscular disease research, drug development, and commercialization in the US and …
ASK4SAM Cements Role As Best NYC Personal Injury Lawyers for Car Accidents in Queens & Bronx with 550th Google Review
GlobeNewswire
·
September 3, 2025
Jamaica, NY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Silberstein …
Conversational AI Interview Tools Rolled Out to Streamline High-Volume Tech Hiring
GlobeNewswire
·
September 3, 2025
Photo Courtesy of: Supportwave LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Supportwave, a next-generation Tech staffing company, has launched a conversational interview platform aimed at overhauling technical hiring for enterprise clients. The platform …
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
GlobeNewswire
·
September 3, 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …